申请人:GLAXO GROUP LTD
公开号:WO2003042228A1
公开(公告)日:2003-05-22
The present invention relates to 14 or 15 membered macrolides substitued at the 4' position of formula (I) and pharmaceutically acceptable salts and solvates thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical bacterial infections in a human or animal body.